| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | actin binding | ESPN BIN1 ABI3 MAP1A ABI3BP CAMK2B ESPNL PTK2 XIRP2 MICAL2 PLEC AJUBA SAMD14 TNS1 | 1.76e-04 | 479 | 187 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | CNKSR1 BIN1 ABI3 WWC3 MAP1A RBBP8 OBSL1 PEX6 GRB10 GON4L TUT1 CAMTA2 ATG2A HIF1AN KMT2D BAZ2A ATF7IP TONSL HELZ2 PKN1 DOT1L AJUBA PRDM16 TNS3 | 2.22e-04 | 1160 | 187 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | RNA uridylyltransferase activity | 2.60e-04 | 3 | 187 | 2 | GO:0050265 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.98e-04 | 227 | 187 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | CNKSR1 BIN1 ABI3 TANK WWC3 MAP1A RBBP8 OBSL1 PEX6 GRB10 GON4L E2F1 TUT1 CAMTA2 ATG2A HIF1AN KMT2D BAZ2A ATF7IP TONSL HELZ2 PKN1 DOT1L AJUBA PRDM16 TNS3 | 3.91e-04 | 1356 | 187 | 26 | GO:0060090 |
| GeneOntologyCellularComponent | centrosome | CYLD ATF5 CAMK2B OBSL1 RAP1GAP2 E2F1 TESK1 PTK2 IFT52 UBN1 CEP78 CTDP1 ZFYVE26 PPP1R35 AJUBA PLK1 CSPP1 PLK3 MTUS2 CCDC116 | 2.34e-05 | 770 | 189 | 20 | GO:0005813 |
| GeneOntologyCellularComponent | microtubule organizing center | CYLD ATF5 CAMK2B DZIP1L OBSL1 RAP1GAP2 E2F1 TESK1 PTK2 IFT52 MAPK15 UBN1 CEP78 CTDP1 ZFYVE26 PPP1R35 AJUBA PLK1 CSPP1 PLK3 MTUS2 CCDC116 | 3.11e-05 | 919 | 189 | 22 | GO:0005815 |
| GeneOntologyCellularComponent | dendritic shaft | 5.61e-05 | 74 | 189 | 6 | GO:0043198 | |
| GeneOntologyCellularComponent | cell leading edge | JCAD ABI3 ABI3BP BCAS3 INPP5E APC2 PLXND1 TESK1 CDC42BPB PTK2 NHS AJUBA PLEKHO1 PHLDB2 | 1.92e-04 | 500 | 189 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | lamellipodium | 2.55e-04 | 230 | 189 | 9 | GO:0030027 | |
| GeneOntologyCellularComponent | dendritic microtubule | 4.82e-04 | 4 | 189 | 2 | GO:1901588 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA6C NDOR1 SETD1B BCAS3 INPP5E RAP1GAP2 PEX6 LAMA5 GRB10 PLXND1 GRIN2D ATG2A TEP1 TESK1 ZDHHC8 CDC42BPB CIC GGA3 KMT2D UBN1 CTDP1 SEC16A HELZ2 ANKRD11 ZFYVE26 PKN1 SNX15 LTBP3 PLEC DOT1L PRDM16 PLK3 PRRT4 | 2.56e-15 | 1105 | 192 | 33 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | JCAD ATF5 ACACB MAP1A APC2 ATG2A ZNF804A CIC PTK2 GGA3 ZNF469 FAM193A UBN1 XIRP2 YLPM1 TONSL PRRG4 PLEC AJUBA PLEKHO1 | 4.38e-13 | 430 | 192 | 20 | 35044719 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD JCAD BCAS3 EXPH5 INPP5E MAP3K14 NELFB GRB10 SRSF11 LARP1B TESK1 CIC ITPKB SAMD11 SEC16A ANKRD11 NHS PLEC PLK1 CSPP1 PHLDB2 TNS3 | 2.91e-09 | 861 | 192 | 22 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | CYLD CAD SETD1B MAP1A RBBP8 CAMK2B OBSL1 ZNF318 CIC UBN1 NFATC2IP UBR5 ATF7IP TONSL SEC16A DOT1L | 2.02e-07 | 588 | 192 | 16 | 38580884 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | BIN1 RBBP8 NELFB ZNF318 CIC URGCP KMT2D KANSL2 UBN1 BAZ2A YLPM1 CTDP1 SEC16A HELZ2 PKN1 PLEC PRRC2A PHLDB2 | 3.44e-07 | 774 | 192 | 18 | 15302935 |
| Pubmed | CYLD SETD1B OBSL1 RAP1GAP2 GRB10 GON4L CAMTA2 DCAF5 GGA3 UBR5 BAZ2A SEC16A TET3 | 4.93e-07 | 407 | 192 | 13 | 12693553 | |
| Pubmed | CYLD TOX OBSL1 CDC42BPB UBR5 SEC16A HELZ2 AUTS2 GRIP2 PRDM16 | 5.57e-07 | 225 | 192 | 10 | 12168954 | |
| Pubmed | 6.19e-07 | 13 | 192 | 4 | 22854038 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 9.39e-07 | 184 | 192 | 9 | 32908313 | |
| Pubmed | CYLD DPYSL2 BIN1 CAD CAMK2B APC2 ZNF318 GRIN2D CDC42BPB PTK2 UBR5 ATF7IP YLPM1 SEC16A PKN1 TNS1 PRRC2A KCNT1 PHLDB2 | 1.87e-06 | 963 | 192 | 19 | 28671696 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CYLD DPYSL2 TUT4 MAP1A BCAS3 LARP1B CDC42BPB PTK2 KIF20A FAM193A CEP78 YLPM1 PLEC MAP2K3 PRRC2A TNS3 | 3.05e-06 | 724 | 192 | 16 | 36232890 |
| Pubmed | CNKSR1 DPYSL2 CAD NELFB GRB10 ANKZF1 NFATC2IP CTDP1 SEC16A NHS PKN1 PRRC2A PHLDB2 | 5.07e-06 | 503 | 192 | 13 | 16964243 | |
| Pubmed | SEMA6C RALGDS INPP5E LAMA5 PLXND1 ATG2A URGCP GGA3 NRXN3 AUTS2 SDC3 IGSF9 KCNT1 | 8.68e-06 | 529 | 192 | 13 | 14621295 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN DPYSL2 TUT4 HEBP2 NTF3 BCAS3 CAMK2B GRB10 SRSF11 TEP1 CDC42BPB PTK2 ITPKB GUCY1A1 MICAL2 LMLN ANKRD11 AUTS2 SDC3 IGSF9 PKN1 MAP2K3 TET3 | 8.92e-06 | 1489 | 192 | 23 | 28611215 |
| Pubmed | CYLD JCAD CNKSR1 DPYSL2 BIN1 APC2 OBSL1 RAP1GAP2 HUNK CDC42BPB DCAF5 PTK2 KANSL2 MICAL2 TPP1 YLPM1 LTBP3 PLEC OLIG2 PRRC2A MTUS2 | 9.75e-06 | 1285 | 192 | 21 | 35914814 | |
| Pubmed | ROBO4 RALGDS BIN1 CDHR1 GRB10 IRF3 PTK2 KANSL2 BAZ2A CARF TONSL IGSF9 ZFYVE26 PLEC PLK1 SAMD14 MTUS2 SEZ6 | 1.33e-05 | 1006 | 192 | 18 | 15226823 | |
| Pubmed | CYLD IL16 TUT4 MAP1A GPT OBSL1 PEX6 ZNF318 TEP1 DCAF5 KIF20A ZNF469 ARHGEF33 C1orf226 UBR5 BAZ2A SEC16A PRDM16 PHLDB2 | 1.51e-05 | 1116 | 192 | 19 | 31753913 | |
| Pubmed | INPP5E CDC42BPB UBN1 SEC16A HELZ2 ANKRD11 PLEC AP4M1 PRRC2A TNS3 | 1.75e-05 | 332 | 192 | 10 | 37433992 | |
| Pubmed | RALGDS MAP1A ABI3BP EXPH5 RAP1GAP2 LCP2 CDC42BPB CIC PTK2 ATF7IP PLEC TNS1 | 1.85e-05 | 486 | 192 | 12 | 20936779 | |
| Pubmed | 2.28e-05 | 209 | 192 | 8 | 36779422 | ||
| Pubmed | DPYSL2 BIN1 MAP1A BCAS3 CAMK2B PTK2 PRRT3 PLEC SAMD14 PRRC2A | 2.56e-05 | 347 | 192 | 10 | 17114649 | |
| Pubmed | PLK1 targets CtIP to promote microhomology-mediated end joining. | 3.03e-05 | 2 | 192 | 2 | 30202980 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 28126323 | ||
| Pubmed | Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis. | 3.03e-05 | 2 | 192 | 2 | 12939256 | |
| Pubmed | Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1. | 3.03e-05 | 2 | 192 | 2 | 19826915 | |
| Pubmed | MRCKβ links Dasm1 to actin rearrangements to promote dendrite development. | 3.03e-05 | 2 | 192 | 2 | 33933448 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 35954177 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 19629135 | ||
| Pubmed | Cloning and sequencing of a novel human gene that encodes a putative target protein of Nesh-SH3. | 3.03e-05 | 2 | 192 | 2 | 11501947 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 16478733 | ||
| Pubmed | A novel m6A reader Prrc2a controls oligodendroglial specification and myelination. | 3.03e-05 | 2 | 192 | 2 | 30514900 | |
| Pubmed | Polo-like kinase 3 regulates CtIP during DNA double-strand break repair in G1. | 3.03e-05 | 2 | 192 | 2 | 25267294 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 21225257 | ||
| Pubmed | The dissociation of cohesin from chromosomes in prophase is regulated by Polo-like kinase. | 3.03e-05 | 2 | 192 | 2 | 11931760 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 26654596 | ||
| Pubmed | The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia. | 3.03e-05 | 2 | 192 | 2 | 29742019 | |
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 17495026 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 33012048 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 24535579 | ||
| Pubmed | 3.03e-05 | 2 | 192 | 2 | 15845548 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 5.25e-05 | 235 | 192 | 8 | 30258100 | |
| Pubmed | 6.97e-05 | 77 | 192 | 5 | 22973453 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 8.22e-05 | 322 | 192 | 9 | 39098523 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 35013309 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 29382756 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 11739404 | ||
| Pubmed | p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex. | 9.06e-05 | 3 | 192 | 2 | 24076372 | |
| Pubmed | Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1. | 9.06e-05 | 3 | 192 | 2 | 18062778 | |
| Pubmed | The Deubiquitinase OTUB1 Is a Key Regulator of Energy Metabolism. | 9.06e-05 | 3 | 192 | 2 | 35163456 | |
| Pubmed | Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription. | 9.06e-05 | 3 | 192 | 2 | 22832221 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 20884806 | ||
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 9553131 | ||
| Pubmed | Homeostatic division is not necessary for antigen-specific CD4+ memory T cell persistence. | 9.06e-05 | 3 | 192 | 2 | 22956580 | |
| Pubmed | The ALDH2, IGSF9, and PRDM16 Proteins as Predictive Biomarkers for Prognosis in Breast Cancer. | 9.06e-05 | 3 | 192 | 2 | 36639264 | |
| Pubmed | 9.06e-05 | 3 | 192 | 2 | 29408933 | ||
| Pubmed | Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections. | 9.06e-05 | 3 | 192 | 2 | 17723219 | |
| Pubmed | T-cell receptor signals direct the composition and function of the memory CD8+ T-cell pool. | 9.06e-05 | 3 | 192 | 2 | 20847203 | |
| Pubmed | Oral ivermectin as an unexpected initiator of CreT2-mediated deletion in T cells. | 9.06e-05 | 3 | 192 | 2 | 22344272 | |
| Pubmed | CYLD ACACB NELFB ZNF318 PLXND1 CDC42BPB MFF KIF20A LIPE UBR5 ATF7IP SEC16A PKN1 AP4M1 | 1.16e-04 | 777 | 192 | 14 | 35844135 | |
| Pubmed | ACACB RBBP8 ZNF318 CIC KMT2D FAM193A UBR5 ATF7IP SEC16A PLEC | 1.20e-04 | 418 | 192 | 10 | 34709266 | |
| Pubmed | CYLD CAD ACACB GON4L E2F1 IRF3 ZNF318 DCAF5 CIC KMT2D KANSL2 UBN1 SAMD11 ATF7IP YLPM1 SEC16A AUTS2 DOT1L PRDM16 PRRC2A | 1.36e-04 | 1429 | 192 | 20 | 35140242 | |
| Pubmed | Regulatory T cells require TCR signaling for their suppressive function. | 1.81e-04 | 4 | 192 | 2 | 25821220 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 26926603 | ||
| Pubmed | Mislocalization of SLP-76 leads to aberrant inflammatory cytokine and autoantibody production. | 1.81e-04 | 4 | 192 | 2 | 20029045 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 34080290 | ||
| Pubmed | NIK is a component of the EGF/heregulin receptor signaling complexes. | 1.81e-04 | 4 | 192 | 2 | 12853971 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 19194507 | ||
| Pubmed | Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3. | 1.81e-04 | 4 | 192 | 2 | 15140944 | |
| Pubmed | Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation. | 1.81e-04 | 4 | 192 | 2 | 25257171 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 23826075 | ||
| Pubmed | The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1. | 1.81e-04 | 4 | 192 | 2 | 20484576 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 18348166 | ||
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 11901158 | ||
| Pubmed | Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses. | 1.81e-04 | 4 | 192 | 2 | 21469089 | |
| Pubmed | 1.81e-04 | 4 | 192 | 2 | 37294664 | ||
| Pubmed | 2.03e-04 | 446 | 192 | 10 | 24255178 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | CYLD BCAS3 RAP1GAP2 GRB10 IRF3 ATG2A ANKZF1 HIF1AN KIF20A CEP78 UBR5 SEC16A PPP1R35 AP4M1 AJUBA TNS3 | 2.26e-04 | 1038 | 192 | 16 | 26673895 |
| Pubmed | 2.36e-04 | 22 | 192 | 3 | 12812986 | ||
| Pubmed | 2.40e-04 | 156 | 192 | 6 | 32850835 | ||
| Pubmed | JCAD CAD GRAMD1A CDC42BPB CIC KMT2D C1orf226 YLPM1 SEC16A NHS AJUBA PLK1 CSPP1 TNS1 PRRC2A TNS3 | 2.55e-04 | 1049 | 192 | 16 | 27880917 | |
| Pubmed | DPYSL2 CAD ZNF318 GGA3 KMT2D BAZ2A YLPM1 SEC16A DOT1L PLK1 PRRC2A | 2.58e-04 | 549 | 192 | 11 | 38280479 | |
| Pubmed | 2.76e-04 | 226 | 192 | 7 | 31452512 | ||
| Pubmed | RALGDS OBSL1 PEX6 GON4L SRSF11 COLGALT2 ANKZF1 URGCP PTK2 CEP78 TPP1 TONSL | 2.87e-04 | 650 | 192 | 12 | 38777146 | |
| Pubmed | A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway. | 2.93e-04 | 302 | 192 | 8 | 30561431 | |
| Pubmed | Inactivation of tensin3 in mice results in growth retardation and postnatal lethality. | 3.00e-04 | 5 | 192 | 2 | 15733665 | |
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 19597481 | ||
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 17190795 | ||
| Pubmed | Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin. | 3.00e-04 | 5 | 192 | 2 | 28439015 | |
| Pubmed | A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. | 3.00e-04 | 5 | 192 | 2 | 8415768 | |
| Pubmed | Phosphorylation of synucleins by members of the Polo-like kinase family. | 3.00e-04 | 5 | 192 | 2 | 19889641 | |
| Pubmed | A TRAF3-NIK module differentially regulates DNA vs RNA pathways in innate immune signaling. | 3.00e-04 | 5 | 192 | 2 | 30018345 | |
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 20184394 | ||
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 27378169 | ||
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 28159912 | ||
| Pubmed | Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody. | 3.00e-04 | 5 | 192 | 2 | 12493754 | |
| Pubmed | PLK1-mediated phosphorylation of PPIL2 regulates HR via CtIP. | 3.00e-04 | 5 | 192 | 2 | 36092721 | |
| Pubmed | Structural insights into the functions of TBK1 in innate antimicrobial immunity. | 3.00e-04 | 5 | 192 | 2 | 23746807 | |
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 18583960 | ||
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 33037408 | ||
| Pubmed | 3.00e-04 | 5 | 192 | 2 | 12242661 | ||
| Interaction | TOP3B interactions | SEMA6C CAD NDOR1 SETD1B BCAS3 INPP5E PLEKHA4 RAP1GAP2 PEX6 LAMA5 GRB10 PLXND1 GRIN2D ATG2A TEP1 TESK1 ZDHHC8 CDC42BPB CIC GGA3 KMT2D UBN1 CTDP1 SEC16A HELZ2 ANKRD11 ZFYVE26 PKN1 SNX15 LTBP3 PLEC DOT1L PRDM16 PRRC2A PLK3 PRRT4 | 5.16e-08 | 1470 | 185 | 36 | int:TOP3B |
| Interaction | YWHAG interactions | CYLD JCAD TICRR CAD BCAS3 EXPH5 INPP5E DZIP1L PLEKHA4 NELFB GRB10 SRSF11 LARP1B TESK1 ANKRD55 CIC PTK2 ITPKB GRID2IP CEP78 SAMD11 SEC16A ANKRD11 NHS PLK1 CSPP1 PHLDB2 TNS3 | 1.03e-05 | 1248 | 185 | 28 | int:YWHAG |
| Interaction | DCAF4 interactions | TUT4 SETD1B ACACB E2F1 ATG2A LARP1B ZDHHC8 DCAF5 FAM193A UBR5 BAZ2A SEC16A HELZ2 PHLDB2 | 1.10e-05 | 378 | 185 | 14 | int:DCAF4 |
| Interaction | MAD2L1 interactions | CAD PLEKHA4 E2F1 ZNF318 DCAF5 CIC KIF20A UBR5 ATF7IP CTDP1 MAP2K3 | 2.23e-05 | 252 | 185 | 11 | int:MAD2L1 |
| Cytoband | 9q34.3 | 5.96e-06 | 106 | 192 | 6 | 9q34.3 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.61e-05 | 34 | 112 | 4 | 487 | |
| GeneFamily | Proline rich transmembrane proteins | 2.26e-04 | 4 | 112 | 2 | 688 | |
| GeneFamily | SH2 domain containing | 4.12e-04 | 101 | 112 | 5 | 741 | |
| GeneFamily | Fibronectin type III domain containing | 4.83e-04 | 160 | 112 | 6 | 555 | |
| GeneFamily | LIM domain containing | 4.89e-04 | 59 | 112 | 4 | 1218 | |
| GeneFamily | Non-canonical poly(A) polymerases | 7.83e-04 | 7 | 112 | 2 | 1318 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 1.04e-03 | 8 | 112 | 2 | 837 | |
| GeneFamily | Ankyrin repeat domain containing | 3.97e-03 | 242 | 112 | 6 | 403 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | JCAD CAD OBSL1 LAMA5 FTSJ1 ATG2A ITPKB SEC16A FUCA1 PLEC MAP2K3 | 5.67e-06 | 276 | 189 | 11 | M3063 |
| Coexpression | GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP | 1.34e-05 | 196 | 189 | 9 | M3189 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_DN | 1.57e-05 | 200 | 189 | 9 | M4795 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2B | DPYSL2 IL16 TOX MAP1A ABI3BP PRICKLE1 LCP2 PTK2 GUCY1A1 MICAL2 SDC3 TNS1 | 2.78e-05 | 389 | 189 | 12 | M4995 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 3.31e-05 | 84 | 189 | 6 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 3.78e-05 | 86 | 189 | 6 | MM825 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.38e-07 | 169 | 192 | 8 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.29e-06 | 182 | 192 | 8 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 185 | 192 | 8 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 185 | 192 | 8 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.58e-06 | 187 | 192 | 8 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.16e-06 | 195 | 192 | 8 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.42e-06 | 198 | 192 | 8 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.51e-06 | 199 | 192 | 8 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.51e-06 | 199 | 192 | 8 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-06 | 152 | 192 | 7 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.47e-06 | 161 | 192 | 7 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 164 | 192 | 7 | b895674ed2df87db8fbfb30b7e31620945588491 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 166 | 192 | 7 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.22e-06 | 167 | 192 | 7 | 784776d1fcc098f84d3c2eca58fa56cb9428f434 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 173 | 192 | 7 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.12e-05 | 175 | 192 | 7 | 7be76d39e1a4f4ac709672cd2d409a2523a083ce | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 1.16e-05 | 176 | 192 | 7 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 176 | 192 | 7 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 177 | 192 | 7 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-05 | 177 | 192 | 7 | bb496fbec7cacc52847abe2b2714249c47879763 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 179 | 192 | 7 | 804aa3899585fc7e662eff9f6d41f48655f16dd6 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 179 | 192 | 7 | dd94ebe69ade6f51b94058abe066216f0de9feda | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 180 | 192 | 7 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.34e-05 | 180 | 192 | 7 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 180 | 192 | 7 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-05 | 180 | 192 | 7 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | Healthy_Control-Lymphoid-NK|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.49e-05 | 183 | 192 | 7 | b41b1f32022c8632a638cf1c5523c9a24176f568 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 183 | 192 | 7 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 186 | 192 | 7 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 186 | 192 | 7 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 186 | 192 | 7 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-05 | 186 | 192 | 7 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.65e-05 | 186 | 192 | 7 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-05 | 186 | 192 | 7 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 187 | 192 | 7 | 50d5730e2cd4951d3ad0641fc81ae9f6ddabafe7 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.83e-05 | 189 | 192 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | droplet-Heart|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-05 | 192 | 192 | 7 | 67a7e07a11091120edbccf739836235c422ec9c6 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-05 | 192 | 192 | 7 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.03e-05 | 192 | 192 | 7 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-05 | 194 | 192 | 7 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-HSC-MPP|bone_marrow / Manually curated celltypes from each tissue | 2.17e-05 | 194 | 192 | 7 | 3a7e7acbddc63da44d9a04a5b52adf6934fc83dd | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 198 | 192 | 7 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 198 | 192 | 7 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-05 | 198 | 192 | 7 | faeef749a4b4bdc7f3edb6923e0e248e8b92c9d0 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_CTL|Leuk-UTI / Disease, condition lineage and cell class | 2.55e-05 | 199 | 192 | 7 | b2609f9d716fdd04f35f0da7f8995d28d7df431d | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.64e-05 | 200 | 192 | 7 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-NP|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.17e-05 | 152 | 192 | 6 | b6a7453fbf9f898e4f222b215907c9a110baa2f6 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-05 | 152 | 192 | 6 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.76e-05 | 155 | 192 | 6 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.97e-05 | 156 | 192 | 6 | 203ef22eb76bd2b829b027c30af0557080f4006c | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.18e-05 | 157 | 192 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-basal_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.40e-05 | 158 | 192 | 6 | 98712ed7e8e65e8c5ff9318cf0e0a04e271a055d | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 6.40e-05 | 158 | 192 | 6 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 160 | 192 | 6 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-05 | 164 | 192 | 6 | 1592a5becad7e0f3f990f0d7581d75fcfc7da023 | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|Liver / Manually curated celltypes from each tissue | 8.41e-05 | 166 | 192 | 6 | a176e87aa6eec81d1fb79a028f759182d11b567d | |
| ToppCell | 10x5'-Liver-Hematopoietic_progenitors|Liver / Manually curated celltypes from each tissue | 8.41e-05 | 166 | 192 | 6 | ae967570248cf86ca3ddf55e33bcbb3e4e3684bc | |
| ToppCell | Ionocyte-iono-3|World / Class top | 8.41e-05 | 166 | 192 | 6 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | facs-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.99e-05 | 168 | 192 | 6 | 6c758eb120faf06ff72d157b495e399191c79ec9 | |
| ToppCell | BAL-Control-cDC_6|Control / Compartment, Disease Groups and Clusters | 8.99e-05 | 168 | 192 | 6 | 65ec473cff748b334c0a66e33bc34a8465fe7631 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 8.99e-05 | 168 | 192 | 6 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 169 | 192 | 6 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.29e-05 | 169 | 192 | 6 | 78eb70dd916724e476eabccf18fb7fcec4210308 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_F|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.59e-05 | 170 | 192 | 6 | 71718dcebd48105994c313bb55babc70301170a0 | |
| ToppCell | Globus_pallidus-Endothelial-MURAL-M1(Rgs5Acta2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 173 | 192 | 6 | 51328a60ffaf34fa0f7df6084d348b5efc9917f5 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 173 | 192 | 6 | 30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 173 | 192 | 6 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | Globus_pallidus-Endothelial-MURAL|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 173 | 192 | 6 | b77cd5dbda3a206922f20224f4e10a3bf712f7db | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 173 | 192 | 6 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | facs-Lung-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-04 | 174 | 192 | 6 | a7ade7372e83edd4e3983e77f8417b51f0b47340 | |
| ToppCell | droplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 174 | 192 | 6 | 773329bb91b97578df138446cf62101dd0dad758 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 175 | 192 | 6 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 175 | 192 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 176 | 192 | 6 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-04 | 177 | 192 | 6 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 177 | 192 | 6 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.20e-04 | 177 | 192 | 6 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 177 | 192 | 6 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-04 | 178 | 192 | 6 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 178 | 192 | 6 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 178 | 192 | 6 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 178 | 192 | 6 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c03-MKI67|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.23e-04 | 178 | 192 | 6 | dbde3305e0c6a81593fe614e3f2e746b32cc16a7 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 179 | 192 | 6 | 36ad18f52e175ab636ceaa3be81212fa362c96c1 | |
| ToppCell | droplet-Lung-LUNG-30m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 179 | 192 | 6 | bfc226bcf0b93525992344f968268a261d86fcbf | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 179 | 192 | 6 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.27e-04 | 179 | 192 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.27e-04 | 179 | 192 | 6 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-04 | 180 | 192 | 6 | d8ef44710a77ad0fc03243428e5e1dc4d41200cb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 192 | 6 | 6ac62bf1251978c8c12e715f7b73144fca619794 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.31e-04 | 180 | 192 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 180 | 192 | 6 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Myeloid-1|bone_marrow / Manually curated celltypes from each tissue | 1.35e-04 | 181 | 192 | 6 | ccd0ed30cea3fb41d34f28b3e8d80a94493bef3c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 182 | 192 | 6 | 4a9c13932e7163fd37a3dcc4c6ca3bbea5372459 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-LMPP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.39e-04 | 182 | 192 | 6 | 69b5cae6fe3bbb0fc60bd2f71b6cfa6cbb0b00ee | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.43e-04 | 183 | 192 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 183 | 192 | 6 | 2dde2fb48e7d31271c2f6b1dd74b2ab0b2cb520c | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 192 | 6 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.47e-04 | 116 | 192 | 5 | 605bd4fdf547cc41783e99cd78425760ef6461ef | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 116 | 192 | 5 | 9c92e714e210a2f29a9e228653d4c990ec643c72 | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A | RALGDS BIN1 ATF5 MAP1A E2F1 TUT1 ZNF318 ANKZF1 GGA3 NALF2 PRRC2A | 8.24e-07 | 198 | 188 | 11 | 7035_UP |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | ROBO4 IL16 CAMK2B SNED1 NRXN3 SULT2B1 BAZ2A OLIG2 TNS1 ENPEP | 5.62e-06 | 196 | 188 | 10 | 6715_UP |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | DPYSL2 ABCA3 RAP1GAP2 GON4L ZNF318 PLXND1 PTK2 MAP2K3 PRRC2A | 3.00e-05 | 190 | 188 | 9 | 1103_UP |
| Drug | Quinacrine dihydrochloride dihydrate [6151-30-0]; Up 200; 7.8uM; HL60; HG-U133A | 3.12e-05 | 191 | 188 | 9 | 1563_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.25e-05 | 192 | 188 | 9 | 6986_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A | 3.39e-05 | 193 | 188 | 9 | 1961_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; HL60; HG-U133A | 3.39e-05 | 193 | 188 | 9 | 1363_DN | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 10uM; PC3; HT_HG-U133A | 3.53e-05 | 194 | 188 | 9 | 4559_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 7356_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 1679_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 1861_DN | |
| Drug | Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 5536_UP | |
| Drug | Tetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 2888_DN | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; PC3; HT_HG-U133A | 3.82e-05 | 196 | 188 | 9 | 6323_DN | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 3.98e-05 | 197 | 188 | 9 | 3311_UP | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; MCF7; HT_HG-U133A | 3.98e-05 | 197 | 188 | 9 | 7197_DN | |
| Drug | Sulfadimethoxine [122-11-2]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 4.14e-05 | 198 | 188 | 9 | 3441_DN | |
| Drug | Suramin sodium salt; Up 200; 10uM; MCF7; HT_HG-U133A | 4.14e-05 | 198 | 188 | 9 | 7524_UP | |
| Drug | Norfloxacin [70458-96-7]; Up 200; 12.6uM; PC3; HT_HG-U133A | 4.14e-05 | 198 | 188 | 9 | 2090_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 4.14e-05 | 198 | 188 | 9 | 3785_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 4.14e-05 | 198 | 188 | 9 | 7011_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 4.30e-05 | 199 | 188 | 9 | 3860_DN | |
| Drug | troglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 4.30e-05 | 199 | 188 | 9 | 6191_UP | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.30e-05 | 199 | 188 | 9 | 3273_UP | |
| Drug | Methamphetamine | DPYSL2 BIN1 NEURL2 ACACB MAP1A GPT OBSL1 PUSL1 PEX6 GON4L TUT1 CAMTA2 GRIN2D CIC KIF20A FAM193A BAZ2A ANKRD11 GRIP2 PLEC MAP2K3 PRDM16 PLEKHO1 TNS1 PLK3 CCDC116 | 9.13e-05 | 1401 | 188 | 26 | ctd:D008694 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 9.86e-05 | 173 | 188 | 8 | 5950_DN | |
| Drug | 5182598; Up 200; 25uM; MCF7; HT_HG-U133A_EA | 1.16e-04 | 177 | 188 | 8 | 976_UP | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 1.35e-04 | 181 | 188 | 8 | 1791_DN | |
| Drug | wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.81e-04 | 189 | 188 | 8 | 869_DN | |
| Drug | vinblastine sulfate; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.02e-04 | 192 | 188 | 8 | 7556_UP | |
| Drug | Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 192 | 188 | 8 | 4108_UP | |
| Drug | Forskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A | 2.02e-04 | 192 | 188 | 8 | 7104_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.02e-04 | 192 | 188 | 8 | 6958_UP | |
| Drug | Progesterone [57-83-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.09e-04 | 193 | 188 | 8 | 6646_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.17e-04 | 194 | 188 | 8 | 4961_UP | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.25e-04 | 195 | 188 | 8 | 7264_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.25e-04 | 195 | 188 | 8 | 3278_UP | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 2.25e-04 | 195 | 188 | 8 | 7559_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Up 200; 14.8uM; HL60; HT_HG-U133A | 2.25e-04 | 195 | 188 | 8 | 2906_UP | |
| Drug | Spaglumic acid [4910-46-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 2.25e-04 | 195 | 188 | 8 | 2962_DN | |
| Drug | Cyanocobalamin [68-19-9]; Up 200; 3uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 3252_UP | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 5926_UP | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 3360_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 5230_UP | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 5288_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 1629_DN | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; HL60; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 1294_DN | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 7224_DN | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 4066_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 5249_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 4793_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 3429_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; PC3; HT_HG-U133A | 2.32e-04 | 196 | 188 | 8 | 7256_DN | |
| Drug | Dichlorphenamide [120-97-8]; Down 200; 13.2uM; HL60; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 3027_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 6940_UP | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 4968_DN | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 2.41e-04 | 197 | 188 | 8 | 371_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 4557_DN | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 6326_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 7521_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 1208_DN | |
| Drug | Evoxine [522-11-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 6041_UP | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 4137_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; HL60; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 2558_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 2702_DN | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 2665_UP | |
| Drug | valdecoxib; Down 200; 10uM; PC3; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 6408_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 6359_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; HL60; HT_HG-U133A | 2.41e-04 | 197 | 188 | 8 | 2698_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 2890_UP | |
| Drug | tetraethylenepentamine pentahydrochloride; Down 200; 100uM; MCF7; HG-U133A | 2.49e-04 | 198 | 188 | 8 | 406_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 7168_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 6472_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 4970_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 5479_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 3294_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 6200_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 1544_UP | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 3081_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 4791_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.49e-04 | 198 | 188 | 8 | 983_DN | |
| Drug | estradiol, USP; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 4432_UP | |
| Drug | Methacholine chloride [62-51-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 6248_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 4976_DN | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 5284_UP | |
| Drug | Benzydamine hydrochloride [132-69-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 7169_DN | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 6421_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Up 200; 5uM; PC3; HT_HG-U133A | 2.49e-04 | 198 | 188 | 8 | 3695_UP | |
| Drug | AC1OAGKB | 2.49e-04 | 198 | 188 | 8 | CID006857406 | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 6810_DN | |
| Drug | sulindac sulfone; Down 200; 50uM; MCF7; HG-U133A | 2.58e-04 | 199 | 188 | 8 | 309_DN | |
| Drug | Buflomedil hydrochloride [35543-24-9]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 3274_UP | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; PC3; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 6355_DN | |
| Drug | Lysergol [602-85-7]; Up 200; 15.8uM; HL60; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 1325_UP | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 3615_UP | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 7185_UP | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 3265_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Down 200; 8.4uM; PC3; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 6312_DN | |
| Drug | Flurbiprofen [5104-49-4]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 5269_UP | |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; HL60; HT_HG-U133A | 2.58e-04 | 199 | 188 | 8 | 2464_UP | |
| Disease | Intellectual Disability | RALGDS CNKSR1 INPP5E CAMK2B APC2 PEX6 GON4L GRIN2D CIC TPP1 SERAC1 FUCA1 AP4M1 TET3 | 7.64e-07 | 447 | 181 | 14 | C3714756 |
| Disease | Profound Mental Retardation | 2.51e-05 | 139 | 181 | 7 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.51e-05 | 139 | 181 | 7 | C0025363 | |
| Disease | Mental deficiency | 2.51e-05 | 139 | 181 | 7 | C0917816 | |
| Disease | autosomal recessive nonsyndromic deafness 36 (implicated_via_orthology) | 3.74e-05 | 2 | 181 | 2 | DOID:0110494 (implicated_via_orthology) | |
| Disease | eosinophil count | ZBTB7C ST20-AS1 EMB RBBP8 MAP3K14 RAP1GAP2 GRB10 LCP2 ZDHHC8 ITPKB FAM193A NEURL3 ATF7IP SEC16A HELZ2 ANKRD11 SDC3 FUCA1 LTBP3 PLEC AJUBA OLIG2 TET3 | 4.41e-05 | 1488 | 181 | 23 | EFO_0004842 |
| Disease | Malignant neoplasm of breast | ABCA3 TANK APC2 E2F1 ZNF318 COLGALT2 GRIN2D TESK1 CIC GGA3 KMT2D LIPE FAM217B NHS ZFYVE26 TNS1 ENPEP PRRC2A | 1.16e-04 | 1074 | 181 | 18 | C0006142 |
| Disease | brain measurement, neuroimaging measurement | DPYSL2 PRR23A TANK GRB10 SLC12A8 HIF1AN PTK2 CARF IGSF9 PLEC PRDM16 TNS1 | 1.61e-04 | 550 | 181 | 12 | EFO_0004346, EFO_0004464 |
| Disease | Adenocarcinoma of large intestine | 3.20e-04 | 96 | 181 | 5 | C1319315 | |
| Disease | restrictive cardiomyopathy (is_implicated_in) | 5.52e-04 | 6 | 181 | 2 | DOID:397 (is_implicated_in) | |
| Disease | lung small cell carcinoma (is_implicated_in) | 6.64e-04 | 28 | 181 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 7.70e-04 | 7 | 181 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | immature platelet measurement | 8.54e-04 | 119 | 181 | 5 | EFO_0803541 | |
| Disease | Autism Spectrum Disorders | 1.88e-03 | 85 | 181 | 4 | C1510586 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.98e-03 | 11 | 181 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | myeloid white cell count | JCAD BIN1 SETD1B ST20-AS1 INPP5E GRAMD1A MAP3K14 CIC KANSL2 GUCY1A1 MICAL2 DOT1L TNS3 SERTAD3 | 2.00e-03 | 937 | 181 | 14 | EFO_0007988 |
| Disease | body surface area | TICRR GRB10 COLGALT2 HIF1AN NRXN3 UBN1 ANKRD11 AUTS2 LTBP3 PLEC DOT1L | 2.17e-03 | 643 | 181 | 11 | EFO_0022196 |
| Disease | brain disease (is_implicated_in) | 2.37e-03 | 12 | 181 | 2 | DOID:936 (is_implicated_in) | |
| Disease | ovary epithelial cancer (is_marker_for) | 2.79e-03 | 13 | 181 | 2 | DOID:2152 (is_marker_for) | |
| Disease | Alzheimer disease | 3.18e-03 | 485 | 181 | 9 | MONDO_0004975 | |
| Disease | Acute Confusional Senile Dementia | 3.28e-03 | 99 | 181 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.28e-03 | 99 | 181 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.28e-03 | 99 | 181 | 4 | C0750901 | |
| Disease | Presenile dementia | 3.28e-03 | 99 | 181 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.28e-03 | 99 | 181 | 4 | C0494463 | |
| Disease | Familial Alzheimer Disease (FAD) | 3.40e-03 | 100 | 181 | 4 | C0276496 | |
| Disease | Alzheimer's Disease | 3.52e-03 | 101 | 181 | 4 | C0002395 | |
| Disease | cortical thickness | DPYSL2 PRR23A INPP5E ESPNL SLC12A8 ZNF318 PLXND1 HIF1AN ZNF469 UBN1 YLPM1 AUTS2 IGSF9 PLEC TNS1 | 3.71e-03 | 1113 | 181 | 15 | EFO_0004840 |
| Disease | Diuretic use measurement | 3.96e-03 | 169 | 181 | 5 | EFO_0009928 | |
| Disease | mean reticulocyte volume | CAD GRB10 ZNF318 ZNF469 IFT52 ATF7IP TONSL HELZ2 PLK1 MAP2K3 PRDM16 SERTAD3 | 3.98e-03 | 799 | 181 | 12 | EFO_0010701 |
| Disease | lung small cell carcinoma (is_marker_for) | 4.24e-03 | 16 | 181 | 2 | DOID:5409 (is_marker_for) | |
| Disease | Schizoaffective disorder-bipolar type | 4.24e-03 | 16 | 181 | 2 | EFO_0009965 | |
| Disease | vitamin C measurement | 4.24e-03 | 16 | 181 | 2 | EFO_0600003 | |
| Disease | intraocular pressure measurement | 4.35e-03 | 509 | 181 | 9 | EFO_0004695 | |
| Disease | mortality | 4.37e-03 | 173 | 181 | 5 | EFO_0004352 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.78e-03 | 335 | 181 | 7 | EFO_0009931 | |
| Disease | Sjogren's syndrome (implicated_via_orthology) | 4.79e-03 | 17 | 181 | 2 | DOID:12894 (implicated_via_orthology) | |
| Disease | schizophrenia, inflammatory bowel disease | 5.37e-03 | 18 | 181 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | immature platelet fraction | 5.41e-03 | 114 | 181 | 4 | EFO_0009187 | |
| Disease | monocyte percentage of leukocytes | SEMA6C BIN1 ST20-AS1 INPP5E MAP3K14 ANKRD55 CTDP1 SEC16A PRDM16 SERTAD3 SECTM1 | 5.66e-03 | 731 | 181 | 11 | EFO_0007989 |
| Disease | breast cancer (is_marker_for) | 5.79e-03 | 185 | 181 | 5 | DOID:1612 (is_marker_for) | |
| Disease | Antihypertensive use measurement | 6.04e-03 | 265 | 181 | 6 | EFO_0009927 | |
| Disease | platelet crit | JCAD MAP1A BCAS3 EXPH5 MAP3K14 LAMA5 ZNF318 DQX1 YLPM1 PRRG4 PLEC DOT1L PRDM16 | 6.07e-03 | 952 | 181 | 13 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLQPPASPQLPRSLD | 176 | Q96P26 | |
| RPPLDQPLELAPLTT | 556 | Q9NWW7 | |
| ALLDLVVSPPAPTDP | 356 | P24298 | |
| PPLTPETLQTLFSAP | 161 | A0A1W2PQ73 | |
| LPIRQEPSSFRAVPP | 796 | Q9Y5B0 | |
| FEPSLRTLPSIGPPS | 231 | Q7L0X2 | |
| LLSPDPTAAFLLPPS | 16 | Q9Y4X3 | |
| NSPESSLLPRAPALP | 781 | Q96JP9 | |
| FPTSLEPTSDLPPLG | 336 | Q8IYX3 | |
| PPDQASTRLPAELEP | 2191 | Q6UB99 | |
| PPQEELPTRVSSPVF | 316 | Q99708 | |
| TRALPLPQSLPPDFR | 96 | Q96IF1 | |
| LPQSLPPDFRLEPTA | 101 | Q96IF1 | |
| LRPSADPIFEPRQLP | 1481 | Q9UIF9 | |
| IPPQDPASPSFTLLS | 26 | A6NJG6 | |
| PFRSINIPEPVLPSE | 141 | A8MVX0 | |
| FAEPLEIRPSPPTSR | 301 | O94983 | |
| TTSLFPLFPNPGPRE | 181 | Q99758 | |
| LLSQESRTEPTRPPP | 316 | Q3KP44 | |
| DARIPLPLDSFPVPV | 606 | Q5JTW2 | |
| PSPVLQPRDPSSTLE | 901 | Q8TEK3 | |
| PLPTNESQPLSLFPT | 911 | Q9H6U6 | |
| LSETRPEALPPPSSN | 561 | P78312 | |
| LDLPSFAPPAQLAPT | 1006 | Q2TAZ0 | |
| ITVSDPPFDTQPRPD | 706 | Q96CP6 | |
| LSDDLPSPLPFRLFP | 286 | O00189 | |
| PSFDLPQPPVLDTLD | 146 | Q9Y2D1 | |
| VPPPTDSARLLNTSP | 571 | Q5JR59 | |
| PSPVSLPLDRPQETR | 161 | Q96I51 | |
| SVDPRLPSPFDIPQI | 141 | O95072 | |
| LQRNFPDPDTPPLTI | 271 | Q5VVQ6 | |
| EVFQRPPTLEELSPP | 251 | Q9P2A4 | |
| TPISFETPSNPPLAR | 631 | O00763 | |
| RTLQVALPSTPAEPP | 556 | Q8IYY4 | |
| ASDPELQPAERPLPS | 106 | O75147 | |
| FPPPPLLATRRSLED | 341 | Q6ZVH7 | |
| SFLNPPLPPSIDDRD | 2451 | P78559 | |
| PLDFLDLERPPTTPQ | 126 | Q9GZY8 | |
| PRPPPALSLDIASDS | 191 | Q9NRR6 | |
| RSPRAPEPALEPESL | 116 | Q8N729 | |
| SFPTRPIPRLSQSDP | 36 | Q9NWT6 | |
| PSRLLLQPSPQRADP | 1 | A0A0A0MT76 | |
| PLSPDPTTPDFLNSL | 306 | Q16555 | |
| PRQTLDALLPPDTSP | 261 | Q8TD08 | |
| IPSEQQFDPPRPLES | 111 | Q9Y5Z4 | |
| NPSRDPPPSIFTFIA | 231 | A0A075B734 | |
| FLPDLPSAPFVPRDA | 191 | Q5U4P2 | |
| PESPQEELLSRPAPA | 1121 | Q9P266 | |
| FQPDSPLPSVSPALS | 686 | B1AK53 | |
| PPETDPPATNLTRAL | 606 | Q96KR4 | |
| LINPPPDTRLEPSDI | 1176 | Q5JUK3 | |
| ELETPCLTLSPSPFP | 381 | Q8N187 | |
| PTSPQDCPRTLLSPL | 746 | Q9Y4D7 | |
| LRVLEPFPTETPPLA | 6 | Q13608 | |
| DVLPPPSQLPSARER | 1116 | Q1MSJ5 | |
| DLSDSERIPIPPSPL | 96 | Q9NTX9 | |
| FISLPQLPPSAVPAE | 441 | P04066 | |
| SIASSRLPQESPPLP | 556 | Q14005 | |
| RLPQESPPLPESRDS | 561 | Q14005 | |
| EDPLATPPIATRAPS | 1346 | Q9Y4C0 | |
| TEPQLRAPSPDPDLV | 311 | Q8WXX7 | |
| ELDTDLFPRPRSPSP | 541 | Q96JK2 | |
| LFPRPRSPSPEDESS | 546 | Q96JK2 | |
| AAETPALELPLPSVP | 561 | Q8WX92 | |
| PPVSLSTPDPLFQLS | 611 | A0A1B0GTW7 | |
| SDNQRRLSPPFPLEP | 1746 | Q8NEV8 | |
| LQPPSGTELSPFSPI | 656 | Q9NZ52 | |
| QSLQRLFEPTTPAPP | 151 | O75949 | |
| LRPPDSLSRAPAEFP | 166 | O75949 | |
| LLDPRANPSQPPSDL | 561 | Q07075 | |
| PLRARNLPPSFFTEP | 221 | A6NEQ2 | |
| RPPTAVDPDAEPTLL | 1266 | O15230 | |
| DLPLSAVPPSQEERP | 1606 | Q9Y5S2 | |
| IQPDLSDRPTPSDPQ | 671 | Q9Y5G1 | |
| SPRVLLSDSTPLEPP | 101 | P20783 | |
| EAAAPSRPPTLLVEP | 131 | Q9BR09 | |
| SFLELEAPPLPQPRV | 391 | Q8TE96 | |
| LQPREPDVSSPTRLP | 276 | Q9UHB4 | |
| LEELPPATPSPRLAL | 616 | Q06495 | |
| DDLSSPPSALPTPQF | 796 | Q96MT3 | |
| PARTQPSLIADETPP | 1561 | O95996 | |
| ELATLSQPPRSATPP | 1851 | O95996 | |
| LPTLQPAVFPPSFRE | 331 | Q9Y366 | |
| LDLESEPTPEPQPRS | 481 | A4D2P6 | |
| PDLLLFATPQAPRPT | 61 | Q01094 | |
| PSPADPRVLSLLSAP | 516 | Q9H8Y5 | |
| DPLRSLPSPLPQEFT | 341 | Q96LA6 | |
| RSVLQETFPRLDPPP | 106 | A1L170 | |
| PSDRLPSAEAQLLPP | 476 | Q9H972 | |
| PSADRPLEASLPPLQ | 681 | P57058 | |
| ALPAVPPEARTSFPL | 1071 | Q3T8J9 | |
| PQPQRLPPEAASTSL | 1146 | Q6VMQ6 | |
| PDLPPSRSAVEIAPT | 556 | Q9NS15 | |
| PELELALTPARAPSP | 271 | Q12967 | |
| PPSPLLFDPSLTLED | 421 | Q9H9L4 | |
| RTSSLPAIPNPFPEL | 131 | Q13322 | |
| FSPALPPLRSPCSEL | 86 | Q9NWW0 | |
| SPPSPLFLEAPSRQA | 71 | Q9H2J1 | |
| APDSPFTSPPLREEI | 36 | Q6PCB8 | |
| ISTDFDRSSPPLQPP | 391 | Q9NQC7 | |
| LPPPTSLDTVPSRDE | 611 | Q8IYK4 | |
| LLFPSNRETLPDPCP | 1756 | Q9BYK8 | |
| LSSPPLVCFIEPDSP | 481 | Q9C0E4 | |
| LDLDFDPLPPVTSPV | 391 | O00499 | |
| PRALPRPATTQEPDI | 256 | O75056 | |
| SPPSFPVEISDRLPA | 511 | A0AV02 | |
| LLPPDTLPLRPAVDS | 211 | P0C264 | |
| APSLSELDLRPPSPI | 796 | Q5FWE3 | |
| ELRPLPPSPIEDSQL | 206 | Q8N813 | |
| PPSSRVPFPERLEAE | 231 | Q8NCU7 | |
| PPRSVPPTDFSQLID | 301 | Q659C4 | |
| LSPSTPSDVNFLLPP | 901 | Q05469 | |
| EEATPSPSPPLKRQF | 766 | O94851 | |
| EPLPLSSLEPAPARN | 741 | Q99558 | |
| LRSPSLDNPTPFPNL | 171 | Q14653 | |
| PNPTPPRNLDSRTFI | 36 | P46734 | |
| RPPFPPEVLAEALNT | 86 | Q8N0Z8 | |
| SPLPAPSPRISDILN | 441 | Q13554 | |
| ESDLRFFLLPPPLPS | 186 | Q96JX3 | |
| DATLPDRPLSPPLTA | 36 | Q684P5 | |
| RSPQPAERVDPALPL | 221 | Q96IW2 | |
| PSLEPNTSLEREPRP | 331 | O00204 | |
| FIPPAPVLPSRDNEI | 251 | Q9BUD6 | |
| FDPEFRLLEPVPSSP | 216 | A6NEV1 | |
| ETLRSNPPPSLAITP | 1121 | Q6T4R5 | |
| DLFTPLSRPPSPLSL | 231 | Q9H4M7 | |
| FLFPPAESLSPEEPR | 56 | P27987 | |
| PQEISPPPTANLDRS | 906 | Q05397 | |
| GLDLSLSPRPDSPQP | 41 | Q8TAP8 | |
| NFRSPPPTLSDPILR | 931 | Q9HAZ2 | |
| FTATPAEPRPLTSPL | 796 | P48634 | |
| SFPLLDPSDAPFPSL | 341 | Q92844 | |
| SFSERELPQPPPLLS | 286 | Q96NU1 | |
| RRSLDEDEPPPSPLT | 106 | Q8IZD0 | |
| ELSPPQPLFRPRSEF | 1661 | Q9UPS6 | |
| RPSSPEPDDLFLPAR | 11 | Q13516 | |
| EAPTLSPPRDARPLT | 911 | Q16512 | |
| EPPDSLAPPSSQAFL | 1006 | Q68CZ2 | |
| EFLDLDNSPLSPPSP | 191 | Q8NCF5 | |
| DELLSDLTRTPPPPS | 541 | Q86SQ0 | |
| TLQLRAEEPPTPALP | 286 | Q53GL0 | |
| PPSPRDEIFLTPNLS | 936 | Q8WZ75 | |
| APETPTQPPRFSELV | 1236 | Q8TER0 | |
| PPQPDPVFLEALSSR | 126 | Q9UJW9 | |
| PEFILTQSPPELAPA | 316 | E9PGG2 | |
| ELPEFRPEEVLPSPT | 1361 | Q96RK0 | |
| PSLSLAPLSPRAPSE | 306 | Q969H4 | |
| VTAFSQSPELPSPPR | 291 | A4UGR9 | |
| FSELPTPDTPVNPLD | 171 | Q8TCY9 | |
| VPDLTPPNPARSLFA | 331 | Q9H4B4 | |
| PPELSQRATLDTVPP | 1361 | Q7Z2Z1 | |
| TPDSEPTPRPLALVF | 211 | Q8WVN6 | |
| SLRPLEEDTPSPLAP | 876 | Q99973 | |
| PPPFTPSLLEQEVRA | 146 | Q96FF7 | |
| LPIPSNLFVPTPDAE | 2221 | O15027 | |
| ELRLFPPDDSPLPVS | 61 | Q05519 | |
| LEPPTPTDLPSARAR | 66 | Q8NBB2 | |
| RIEDSTTASPPPLPL | 446 | A6NFA1 | |
| PDTAPLPVPANIRFS | 286 | O95235 | |
| SPQSLPPASPLLEDR | 301 | Q9H6E5 | |
| TPSSLLFDPETSPPL | 681 | Q96HA7 | |
| VRDFPPPALSLELQP | 271 | Q9BTD3 | |
| SFSEAEPQLPPAPVR | 621 | Q9HBL0 | |
| VASRPSPQPLAETPI | 676 | Q9HBL0 | |
| AETPIPSLPEFPRAA | 686 | Q9HBL0 | |
| PPPSSPAQEALDLLF | 176 | Q9NRS6 | |
| PPEAPRPLFFLTLEA | 336 | C9JH25 | |
| DLPPASASRSVPIPL | 591 | Q9H3T2 | |
| PFTPSPLPRLANQDS | 101 | Q53EL9 | |
| APETVPSAPENPRIF | 1036 | P08922 | |
| LPRAAALERTEPSPP | 541 | Q15569 | |
| FRRPEEAALSPLPPS | 166 | Q9BZD6 | |
| PEPSPAAPTLRSELE | 1191 | Q15149 | |
| PAPSTRPLLSSEVPQ | 316 | O43151 | |
| LFAPSPSRDSLLPPT | 666 | O43151 | |
| FLRSPETPPVSPRES | 966 | Q9P2J2 | |
| RPLPTTVQAASPLPE | 81 | A8MZF0 | |
| SSLPFLDPNARPLVP | 146 | P27708 | |
| SQFRERDIPSLPPLP | 1321 | P49750 | |
| PSLPPFLCPDLEEQS | 91 | Q96EH8 | |
| PLPREDPLTSPSRAQ | 2101 | Q96JG9 | |
| TPLTREDRPALQEPP | 121 | Q96JL9 | |
| PISRVDTFPQPLAAP | 296 | Q9UET6 | |
| IPDRRPSLSPFAPDF | 241 | A1YPR0 | |
| PPPASSLQSPLNFLA | 726 | Q9NPG3 | |
| TDLPEPPPSLTVQRD | 696 | Q9ULC8 | |
| LIPSRDSESPLPPLT | 546 | Q8N3L3 | |
| QPRATLAPSETPFVP | 421 | Q7Z7G0 | |
| QEESELRSLPPPSPA | 336 | Q5TAX3 | |
| EALELPEPRTPPLSS | 1096 | Q68DK2 | |
| PEPRTPPLSSLVEQA | 1101 | Q68DK2 | |
| PSLESEDFNIPPITP | 61 | O94900 | |
| VRPPPPLSSVFSEQA | 1536 | Q5VUA4 | |
| SPLDTPFLPASRDSP | 466 | Q9ULE0 | |
| RPRELESPVPDSPQL | 16 | Q9BXU0 | |
| EELFSVEPLPPRPSS | 1511 | O95071 | |
| LPEEFLRPPSTSVAP | 791 | Q7Z570 | |
| IPPRFSIAPSSLDPS | 321 | P53350 | |
| FPPTSSLRQRPEPQV | 176 | O14773 | |
| PRSREELPPNFPSEI | 636 | Q02108 | |
| ASRLFPPFEESPLSP | 596 | O14686 | |
| LDVRQLSAPPPEEPS | 4901 | O14686 | |
| PPLDRSLAPFDREPF | 241 | Q13094 | |
| DLPPPAPTSRSLEDL | 1261 | O15399 |